| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Antigen composition comprising PEB1 and/or PEB3 antigen from Campylobacter jejuni; useful as vaccine and for diagnosis of C. jejuni and Campylobacter coli infections
|
|
|
1992
|
10 |
14 |
p. 1059-
1 p.
|
article
|
| 2 |
Author index
|
|
|
1992
|
10 |
14 |
p. 1061-1069
9 p.
|
article
|
| 3 |
Bacterial vaccines: old and new, veterinary and medical
|
Walker, P.D.
|
|
1992
|
10 |
14 |
p. 977-990
14 p.
|
article
|
| 4 |
Calendar
|
|
|
1992
|
10 |
14 |
p. 1077-
1 p.
|
article
|
| 5 |
Call for papers
|
|
|
1992
|
10 |
14 |
p. 1078-
1 p.
|
article
|
| 6 |
Current status and prospects of live varicella vaccine
|
Takahashi, Michiaki
|
|
1992
|
10 |
14 |
p. 1007-1014
8 p.
|
article
|
| 7 |
Development of a vaccine for the prevention of AIDS, a critical appraisal
|
Karzon, David T.
|
|
1992
|
10 |
14 |
p. 1039-1052
14 p.
|
article
|
| 8 |
Hepatitis C virus asialoglycoprotein-E1 and -E2; useful as vaccine or for diagnosis of non-A non-B hepatitis virus infection, or for concentrating or reducing HCV proteins in biological samples, and obtained by gene expression in yeast
|
|
|
1992
|
10 |
14 |
p. 1060-
1 p.
|
article
|
| 9 |
Impediments, imponderables and alternatives in the attempt to develop an effective vaccine against AIDS
|
Hilleman, Maurice R.
|
|
1992
|
10 |
14 |
p. 1053-1058
6 p.
|
article
|
| 10 |
Molecular design of cholera vaccines
|
Manning, Paul A.
|
|
1992
|
10 |
14 |
p. 1015-1021
7 p.
|
article
|
| 11 |
New approaches to vaccination against foot-and-mouth disease
|
Brown, Fred
|
|
1992
|
10 |
14 |
p. 1022-1026
5 p.
|
article
|
| 12 |
New gene fragment encoding rabies virus glycoprotein; DNA sequence expression in eukaryote cell culture and application to recombinant vaccine construction
|
|
|
1992
|
10 |
14 |
p. 1059-
1 p.
|
article
|
| 13 |
Nucleic acid constructs, malaria polypeptides and vaccines; recombinant malaria serine-repeat antigen production in yeast for the construction of a recombinant vaccine
|
|
|
1992
|
10 |
14 |
p. 1059-
1 p.
|
article
|
| 14 |
Pertussis: the trials and tribulations of old and new pertussis vaccines
|
Cherry, James D.
|
|
1992
|
10 |
14 |
p. 1033-1038
6 p.
|
article
|
| 15 |
Progress towards the development of new vaccines against whooping cough
|
Rappuli, Rino
|
|
1992
|
10 |
14 |
p. 1027-1032
6 p.
|
article
|
| 16 |
Prophylaxis: the foundation for our future progress
|
Spier, R.E.
|
|
1992
|
10 |
14 |
p. 971-976
6 p.
|
article
|
| 17 |
Recombinant feline corona virus-S protein; expressed as galactokinase fusion protein and useful as reconbinant vaccine, therapeutic and diagnostic agents for feline-infectious-peritonitis virus
|
|
|
1992
|
10 |
14 |
p. 1059-1060
2 p.
|
article
|
| 18 |
Recombinant pox virus containing Morbilli virus DNA; expression of e.g. measles virus haemagglutinin glycoprotein in host for construction of a potential recombinant vaccine against dog distemper virus
|
|
|
1992
|
10 |
14 |
p. 1060-
1 p.
|
article
|
| 19 |
Subject index
|
|
|
1992
|
10 |
14 |
p. 1070-1076
7 p.
|
article
|
| 20 |
Synthetic approaches to vaccines for infectious and autoimmune diseases
|
Sela, Michael
|
|
1992
|
10 |
14 |
p. 991-999
9 p.
|
article
|
| 21 |
Synthetic immunoadjuvants: application to non-specific host stimulation and potentiation of vaccine immunogenicity
|
Azuma, Ichiro
|
|
1992
|
10 |
14 |
p. 1000-1006
7 p.
|
article
|
| 22 |
Vaccine comprising anti-idiotype antibody conjugate; induces production of neutralizing antibody (human monoclonal antibody, chimeric antibody or FAb, F(Ab′) 2 or Fv fragment) against HIV virus-1
|
|
|
1992
|
10 |
14 |
p. 1059-
1 p.
|
article
|
| 23 |
Vaccine comprising live attenuated or inactivated rotavirus strains; HRV 89-12C2, HRV 408, HRV 248 HRV 456 and/or CJN, for immunization against rotavirus illnesses
|
|
|
1992
|
10 |
14 |
p. 1060-
1 p.
|
article
|
Journal description